Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Researchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUS
Researchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUS
Researchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUS
Submitted by
admin
on June 12, 2011 - 11:09am
Source:
Benzinga
News Tags:
Soliris
Alexion
atypical hemolytic uremic syndrome
Headline:
Researchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUS
Do Not Allow Advertisers to Use My Personal information